Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ellen Kuenzig

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Clinical Epidemiology|July 25, 2018
Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort studyM Ellen Kuenzig, Mohsen Sadatsafavi, J Antonio Aviña-Zubieta, et al.
Rheumatology (Oxford, England)|September 9, 2021
Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort studyStephen G Fung, Richard Webster, M Ellen Kuenzig, et al.
The Cochrane Database of Systematic Reviews|June 4, 2015
Budesonide for induction of remission in Crohn's diseaseAli Rezaie, M Ellen Kuenzig, Eric I Benchimol, et al.
Gut|January 12, 2019
Inflammatory bowel disease and new-onset psychiatric disorders in pregnancy and post partum: a population-based cohort studySimone N Vigod, Paul Kurdyak, Hilary K Brown, et al.
The Cochrane Database of Systematic Reviews|August 21, 2014
Budesonide for maintenance of remission in Crohn's diseaseM Ellen Kuenzig, Ali Rezaie, Cynthia H Seow, et al.
Clinical Epidemiology|January 5, 2026
Validity of the Leading Causes of Death Classification for Premature Mortality in Inflammatory Bowel Disease: A Population-Based Comparison with ICD-10 Coding in Ontario, CanadaGemma Postill, M Ellen Kuenzig, Pablo A Olivera, et al.
Journal of the Canadian Association of Gastroenterology|December 15, 2025
Models of outpatient care delivery in inflammatory bowel disease: a scoping reviewNoelle Rohatinsky, M Ellen Kuenzig, James Im, et al.
Inflammatory Bowel Diseases|February 2, 2017
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysisStephanie Coward, M Ellen Kuenzig, Glen Hazlewood, et al.
Inflammatory Bowel Diseases|July 28, 2018
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis: RepublishedStephanie Coward, M Ellen Kuenzig, Glen Hazlewood, et al.
Digestive Diseases and Sciences|June 11, 2021
Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital DischargeJeffrey D McCurdy, M Ellen Kuenzig, Sarah Spruin, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Clinical Epidemiology|July 25, 2018
Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort studyM Ellen Kuenzig, Mohsen Sadatsafavi, J Antonio Aviña-Zubieta, et al.
Rheumatology (Oxford, England)|September 9, 2021
Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort studyStephen G Fung, Richard Webster, M Ellen Kuenzig, et al.
The Cochrane Database of Systematic Reviews|June 4, 2015
Budesonide for induction of remission in Crohn's diseaseAli Rezaie, M Ellen Kuenzig, Eric I Benchimol, et al.
Gut|January 12, 2019
Inflammatory bowel disease and new-onset psychiatric disorders in pregnancy and post partum: a population-based cohort studySimone N Vigod, Paul Kurdyak, Hilary K Brown, et al.
The Cochrane Database of Systematic Reviews|August 21, 2014
Budesonide for maintenance of remission in Crohn's diseaseM Ellen Kuenzig, Ali Rezaie, Cynthia H Seow, et al.
Clinical Epidemiology|January 5, 2026
Validity of the Leading Causes of Death Classification for Premature Mortality in Inflammatory Bowel Disease: A Population-Based Comparison with ICD-10 Coding in Ontario, CanadaGemma Postill, M Ellen Kuenzig, Pablo A Olivera, et al.
Journal of the Canadian Association of Gastroenterology|December 15, 2025
Models of outpatient care delivery in inflammatory bowel disease: a scoping reviewNoelle Rohatinsky, M Ellen Kuenzig, James Im, et al.
Inflammatory Bowel Diseases|February 2, 2017
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysisStephanie Coward, M Ellen Kuenzig, Glen Hazlewood, et al.
Inflammatory Bowel Diseases|July 28, 2018
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis: RepublishedStephanie Coward, M Ellen Kuenzig, Glen Hazlewood, et al.
Digestive Diseases and Sciences|June 11, 2021
Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital DischargeJeffrey D McCurdy, M Ellen Kuenzig, Sarah Spruin, et al.
Pageof 9